The effects of vitamin D metabolites on alkaline phosphatase [ALPase; orthophosphoric-monoester phosphohydrolase (alkaline optimum), EC 3.1.3.1] activity, a marker ofterminal differentiation, in chondrocyte cultures and growth plates in vivo were examined. In cultures of pelleted rabbit growth-plate chondrocytes, 1,25-dihydroxycholecalciferol (1,25-dihydroxyvitamin D3) increased the contents of DNA and macromolecules containing uronic acid (proteoglycans). It also decreased ALPase activity with an ED50 of <1 nM. Other vitamin D3 metabolites, such as 24,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol, had little effect on these biochemical parameters. In rachitic growth plates, the uronic acid content was half that in normal growth plates, whereas ALPase activity was 2.5 times that in normal growth plates. Administration of 1,25-dihydroxycholecalciferol at a low dose (0.1 ,ug per kg of body weight) to rachitic rats increased the uronic acid content 1.4-fold and decreased ALPase activity by 40%. This compound, like 24,25-dihydroxycholecalciferol (10 pig per kg
vitamin D3 metabolites, such as 24,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol, had little effect on these biochemical parameters. In rachitic growth plates, the uronic acid content was half that in normal growth plates, whereas ALPase activity was 2.5 times that in normal growth plates. Administration of 1,25-dihydroxycholecalciferol at a low dose (0.1 ,ug per kg of body weight) to rachitic rats increased the uronic acid content 1.4-fold and decreased ALPase activity by 40%. This compound, like 24,25-dihydroxycholecalciferol (10 pig per kg of body weight), increased the calcium level of the blood. However, administration of 24,25-dihydroxycholecalciferol had little effect on the uronic acid and ALPase contents in growth plates. These observations suggest that 1,25-dihydroxycholecalciferol is a bioactive form of vitamin D that plays an important role in the control of chondrocyte terminal differentiation.
In growth plates, chondrocytes undergo cell changes including proliferation, formation of a proteoglycan matrix, terminal differentiation to hypertrophic cells, and calcification until puberty. Hypertrophic chondrocytes and the calcified matrix are invaded by capillaries and chondroclasts and eventually replaced by bone. In the process of endochondral bone formation, vitamin D seems essential; vitamin D deficiency results in abnormal expansion of the growth plate, mainly due to widening of the zone of hypertrophic chondrocytes (1, 2) . In general, the enlargement of the hypertrophic zone is thought to be a consequence of retardation of hypertrophic chondrocyte death due to lack of calcification, because vitamin D deficiency causes a decrease in blood calcium and phosphate levels. However, it could be due to acceleration of differentiation of maturing chondrocytes into hypertrophic cells. To test this possibility, we examined the effects of vitamin D metabolites on alkaline phosphatase [ALPase; orthophosphoric-monoester phosphohydrolase (alkaline optimum), EC 3. (6, 7) .
In the present study, rabbit growth-plate chondrocytes were maintained as a packed mass in a centrifuge tube. These cells became reorganized into a cartilage-like tissue and retained the ability to produce ALPase at a very high level similar to that ofgrowth plates in vivo (8, 9 
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(medium B). In other experiments, 14-day-old cultures were transferred to 1 ml of MEM supplemented with 50 Ag of ascorbic acid and 60 pug of kanamycin per ml in the presence of 10% charcoal-treated serum.
Tissue Preparation. Samples of growth-plate cartilage and permanent cartilage from the ribs were obtained from rachitic or normal rats. For induction of rickets, 21-day-old SpragueDawley rats were housed in the absence of UV light (using a UV-cut filter) and given a vitamin D-deficient diet (Diet-11, Oriental Yeast Co., Tokyo) and distilled water ad libitum for 6 weeks. 1,25(OH)2D3 or 24,25(OH)2D3 was dissolved in triglyceride of medium chain length, and some rachitic rats received oral supplements of these metabolites or solvent alone 1, 3, 5, and 7 days before sacrifice.
Treatment of Serum with Charcoal. Fetal bovine serum was incubated with 10%o volumes (wt/vol) of charcoal at 40C for 24 hr (11), and then the charcoal was removed by centrifugation at 15,000 X g for 30 min. This treatment reduced the 1,25(OH)2D3 concentration from 47 pg/ml to an undetectable level and the 24,25(OH)2D3 concentration from 1.4 ng/ml to 0.7 ng/ml (12) .
Measurement of ALPase Activity. ALPase activity was measured by a modification of the method of Bessey et al. (13) with 2-(p-nitrophenyl) phosphate (pNP) as substrate. Cell pellets or cartilage segments were homogenized with a glass homogenizer in 0.9%6 NaCl/0.2% Triton X-100 at 09C and were centrifuged for 15 min at 12,000 x g. The activity of the supernatant, which contained 95% of the total activity, was assayed in 0.5 M Tris HCl buffer (pH 9.0) containing 0.5 mM pNP and 0.5 mM MgCl2. The reaction-mixture was incubated at 37°C for 15 or 30 min, and the reaction was stopped by addition of 0.25 vol of 1 M NaOH. Hydrolysis of pNP was monitored as change in A410 in a Hitachi spectrometer. Nitrophenol was used as a standard. One unit ofALPase was defined as the amount of enzyme required to hydrolyze 1 nmol of pNP per 30 min at pH 9.0.
Determinations of DNA and Uronic Acid. Cartilage segments or cell pellets were washed with phosphate-buffered saline and then homogenized at 0°C-4°C in 1 ml of 0.9o NaCl/0.2% Triton X-100. The homogenates were then incubated at 37°C for 16 hr with 3 mg of Pronase E (protease type XIV; Sigma) in 3 ml of 0.05 M Tris-HCl buffer (pH 8.0) containing 1 mM CaC12, 0.9%o NaCl, and 0.2% Triton X-100. Digests of tissues or cell pellets were used for assays of DNA (14) and uronic acid (15) .
Determination of Levels of Vitamin D Metabolites in Plasma. Vitamin D metabolites in rat plasma were determined by combinations of Sephadex LH-20 chromatography, HPLC, competitive protein binding assays, and radioreceptor assays (16 Results are averages ± SD for four to six cultures. VD, vitamin D.
Next we examined the effects of vitamin D metabolites on ALPase activity in chondrocytes in medium with 10% charcoal-treated or normal serum. Treatment of fetal bovine serum with charcoal reduced the 1,25(OH)2D3 and 24,25(OH)2D3 concentrations by 95% and 50%, respectively. When 14-day-old chondrocyte cultures were exposed to 10% charcoal-treated serum, ALPase activity increased 1.5 to 2 times more in 24 hr than in cultures with 10o normal serum (Fig. 1B) vitamin D-deficient cultures decreased ALPase activity within 24 hr (Fig. 1B) . The dose dependence of the effect of 1,25(OH)2D3 on ALPase is shown in Fig. 1C (20) .
In experiment 1, but not in experiment 2, the ALPase activity in rachitic plasma was 1.8 times that in normal plasma Results are expressed as averages ± SD for eight rats. *, Not determined.
( Table 3 (19) . TrACPase seems to be a serum marker of bone resorption. The uronic acid content in the growth plate of rachitic rats was 30-50% of that in the growth plate of normal rats (Table  4) . Nevertheless, the ALPase activity was 2.5 times higher in rachitic growth plates. Administration of 1,25(OH)2D3 to rats with rickets had opposite effects on proteoglycan accumulation and ALPase activity in growth plates: it increased the uronic acid content 1.3-to 1.4-fold but decreased ALPase activity by 30-40o in two independent series ofexperiments.
24,25(OH)2D3 had less effect on uronic acid content and no significant effect on ALPase content of growth plates (Table  4) . Vitamin D deficiency had little effect on the uronic acid (Table 4) or ALPase (data not shown) content of resting cartilage.
Growth plates of rachitic rats have a widened zone of hypertrophic chondrocytes (Fig. 2) , as expected from previous studies on rachitic chickens (1, 2) . Treatment with 1,25(OH)2D3 (Fig. 2) , but not 24,25(OH)2D3 (data not shown), 2.02 ± 0.10 Vitamin D metabolites were administered as described in Table 1 . Uronic acid content of the growth plate (Growth) and resting (Resting) cartilage and ALPase activity in growth plate cartilage were determined. Results are expressed as averages ± SD for four determinations with eight rats.
reduced the width of the hypertrophic zone. Sections from vitamin D-deficient rats treated with 1,25(OH)2D3 were indistinguishable from those from normal rats. To our knowledge, this demonstration that 1,25(OH)2D3 alleviates histological signs of rickets in mammalian growth plates has not been reported elsewhere.
DISCUSSION
In adult animals, the deficiency of vitamin D is characterized by impaired calcification of bone matrix. In growing animals, vitamin D deficiency leads to rickets. Rickets is characterized by abnormal widening of the growth plate with chondrocyte hypertrophy, increase in plasma ALPase activity, and the failure of calcification of the growth plate. The features are reversed at least partially by treatment with 1,25(OH)2D3 (1, 2) . However, the mechanism of the vitamin D action is not known.
There have been conflicting reports on the effects of vitamin D metabolites on the synthesis of proteoglycan, a main component of the cartilage matrix, probably because its effects have been examined with chondrocytes in monolayer cultures (12, 21, 22) , whose phenotypic expression is variable at low levels depending on culture conditions. Using cultures of well differentiated chondrocytes in centrifuge tubes and rachitic growth plates in vivo, in the present study we showed that 1,25(OH)2D3 is involved physiologically in supporting the formation of a proteoglycan matrix in growth plates.
Administration of 1,25(OH)2D3 to rachitic rats increased the uronic acid content of growth plates at a dose that increased the 1,25(OH)2D3 level in the blood to the normal level without an increase in the 24,25(OH)2D3 or 25(OH)D3 level. This effect was independent of an increase in the blood calcium level, because 1,25(OH)2D3 increased the uronic acid content of chondrocyte cultures. On the other hand, 24,25(OH)2D3 had little effect on the uronic acid content of chondrocyte cultures, although its administration to rachitic rats slightly increased the uronic acid content of growth plates in vivo.
Other metabolites, such as 25(OH)D3 and 1(OH)D3, had no effect on the uronic acid content of chondrocyte cultures. These results provide evidence that of various vitamin D metabolites, 1,25(OH)2D3 is the most important for supporting cartilage-matrix formation.
The reason why rachitic growth plates have a wider zone of hypertrophic chondrocytes is unknown. This widening may be a result of retardation of hypertrophic chondrocyte death due to lack of calcification in the hypertrophic zone (1, 2) . It is also conceivable that the number of chondroclasts diminishes in rickets, because the formation of osteoclasts has been shown to require 1,25(OH)2D3 (23, 24 The results in the present study suggest that 1,25(OH)2D3 plays a role in inhibiting precocious or excess chondrocyte hypertrophy while stimulating the formation of a proteoglycan matrix in growth plates. The suppression of chondrocyte hypertrophy during the matrix-forming stage may be required for enough accumulation of a calcifiable matrix prior to mineral deposition, because chondrocytes lose proteoglycansynthetic activity once they become hypertrophic (25) . It is unlikely that the effect of 1,25(OH)2D3 on, terminal differentiation is secondary to its effect on extracellular matrix synthesis. Differentiation of chondrocytes to matrixforming stage and terminal differentiation to hypertrophic stage can be separated by manipulation of culture conditions (8, 9) or addition of transforming growth factor type (3 (8) , fibroblast growth factor (25) , or parathyroid hormone (26) . Extracellular matrix synthesis and hypertrophy appear to be regulated by different sets of growth factor and hormones.
The present study also showed that although no calcification occurs in rachitic growth plates, they have a very high level of ALPase activity. This indicates that the decrease in the plasma calcium level predominates over the increase in ALPase activity.
Administration of 1,25(OH)2D3 to rats with rickets had profound effects on the uronic acid content and ALPase activity in growth plates, whereas it had little effect on the biochemical indices in permanent (resting) cartilage. This is in accord with localization of 1,25(OH)2D3 receptors in hypertrophic chondrocytes (9) or growth cartilage (27) . Furthermore (30) and in epiphyses (28, 29) .
We conclude from the present study that 1,25(OH)2D3 is a bioactive form of vitamin D that plays an important role in the control of terminal differentiation of chondrocytes in growth plates. This information is important in understanding the role of vitamin D in endochondral bone formation.
We thank Mrs. Elizabeth Ichihara for critical reading of this manuscript.
